Sunday 9 May
Sunday 30 May
- Medicines - Conclusion of non-exclusive pharmaceutical rebate agreements under § 130a para. 8 SGB V via an open-house model for the active substance Denosumab Prolia (WHO ATC code: M05BX04)
- Medicines - Open-House Rebate Contracts 2025-05
- Medicines - Open house discount agreements for the active substance Liraglutide, ATC A10BJ02
- +1 more